ASRCX
Price
$7.85
Change
+$0.04 (+0.51%)
Updated
Apr 24 closing price
Net Assets
350.49M
MGLIX
Price
$15.77
Change
+$0.13 (+0.83%)
Updated
Apr 24 closing price
Net Assets
2.19B
Ad is loading...

ASRCX vs MGLIX

Header iconASRCX vs MGLIX Comparison
Open Charts ASRCX vs MGLIXBanner chart's image
Invesco Global Real Estate Income C
Price$7.85
Change+$0.04 (+0.51%)
VolumeN/A
Net Assets350.49M
MFS Global Real Estate I
Price$15.77
Change+$0.13 (+0.83%)
VolumeN/A
Net Assets2.19B
ASRCX vs MGLIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ASRCX vs. MGLIX commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASRCX is a StrongBuy and MGLIX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
MGLIX has more cash in the bank: 2.19B vs. ASRCX (350M). ASRCX pays higher dividends than MGLIX: ASRCX (2.77) vs MGLIX (2.61). ASRCX was incepted earlier than MGLIX: ASRCX (18 years) vs MGLIX (16 years). ASRCX (2.01) is less costly to investors than MGLIX (0.95). ASRCX (49.00) and MGLIX (48.00) have comparable annual turnover. MGLIX has a lower initial minimum investment than ASRCX: MGLIX (0) vs ASRCX (1000). ASRCX annual gain was more profitable for investors over the last year : 2.96 vs. MGLIX (2.35). MGLIX (21.58) and ASRCX (20.70) have equivalent 5 years return.
ASRCXMGLIXASRCX / MGLIX
Total Expense Ratio2.010.94214%
Annual Report Gross Expense Ratio2.010.95212%
Fund Existence18 years16 years-
Gain YTD-0.540-2.49422%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets350M2.19B16%
Annual Yield % from dividends2.772.61106%
Returns for 1 year2.962.35126%
Returns for 3 years-11.71-21.1655%
Returns for 5 years20.7021.5896%
Returns for 10 years5.9219.2131%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TOCQX43.02N/A
N/A
Tocqueville
JFNAX63.90N/A
N/A
Janus Henderson Global Life Sciences A
GMVRX14.37N/A
N/A
Goldman Sachs Small/Mid Cap Value R
NSFOX10.22N/A
N/A
Natixis Target Retirement 2065 N
GTDIX33.14N/A
N/A
Invesco EQV Emerging Markets All Cap R5